Cardiac magnetic resonance (CMR) it is a technique without radiation, which is considered the gold-standard for the evaluation of cardiac anatomy, function and even tissue composition. The RESILIENCE trial will use CMR as the main outcome measure methodology, and patients enrolled in the trial will undergo 3 scans across the duration of the study.
Multinational, prospective, proof of concept phase II, double-blinded, sham-controlled, randomized clinical trial (RCT) to evaluate the efficacy and safety of Remote Ischaemic Conditioning (RIC) in Lymphoma patients receiving anthracyclines. Patients scheduled to undergo ≥5 chemotherapy cycles will be eligible.
How research is changing the way we protect the hearts of people with cancer. In recent years, cardio-oncology has evolved from an emerging discipline into a key area of cancer patient care. As cancer survival rates continue to improve, preventing, detecting, and treating the cardiovascular complications associated with certain cancer therapies has become increasingly important. […]
